I 115th CONGRESS 1st Session H. R. 1063 IN THE HOUSE OF REPRESENTATIVES February 15, 2017 Mr. O'Rourke (for himself, Mr. Coffman , Mr. Jones , Mr. Peters , Miss Rice of New York , and Ms. Titus ) introduced the following bill; which was referred to the Committee on Veterans' Affairs A BILL To ensure that an individual who is transitioning from receiving medical treatment furnished by the Secretary of Defense to medical treatment furnished by the Secretary of Veterans Affairs receives the pharmaceutical agents required for such transition.

1. Short title This Act may be cited as the Veteran Prescription Continuity Act . 2. Improvement to transition of care of veterans Section 715 of the National Defense Authorization Act for Fiscal Year 2016 ( Public Law 114–92 ; 10 U.S.C. 1074g note) is amended— (1) by redesignating subsections (c) through (f) as subsections (d) through (g), respectively; and (2) by inserting after subsection (b) the following new subsection (c): (c) Other pharmaceutical agents (1) Critical for transition The Secretary of Veterans Affairs shall furnish to an individual who is transitioning from receiving treatment furnished by the Secretary of Defense to treatment furnished by the Secretary of Veterans Affairs pursuant to chapter 17 of title 38, United States Code, any pharmaceutical agent not included in the joint uniform formulary if a health care provider of the Department of Defense determines that such pharmaceutical agent is critical for such transition. (2) Duration The Secretary of Veterans Affairs shall furnish to an individual a pharmaceutical agent under paragraph (1) during the period— (A) beginning on the date on which the individual is enrolled in the health care system of the Department of Veterans Affairs established under section 1705 of title 38, United States Code; and (B) ending on the date on which a health care provider of the Department determines that the individual does not require such pharmaceutical agent. .